Monitoring ovarian carcinoma with CA 125, CA 19–9, CA 15–3 and CEA in serum, ascites and tumor tissue

Autor:	Hartmut Arps, S. Müller-Hagen, M. Dietal, R. Klapdor, E. Schäfer, L. Hoffmann
Rok vydání:	1986
Předmět:	Oncology Cancer Research medicine.medical_specialty Hematology business.industry Granulosa cell CA 15-3 General Medicine Luteal phase medicine.disease Premature ovarian failure Ovarian carcinoma Internal medicine Ascites medicine Cancer research CA19-9 medicine.symptom business
Zdroj:	Journal of Cancer Research and Clinical Oncology. 111:S134-S134
ISSN:	1432-1335 0171-5216
DOI:	10.1007/bf02580306
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2bb1cca13f5b2443b6e8a0e60d2e053e https://doi.org/10.1007/bf02580306 Zobrazit plný text záznamu Full text from SpringerLink